Cumberland Pharmaceuticals Pitch Deck slide image

Cumberland Pharmaceuticals Pitch Deck

750 NDC 62847-001-01 VIBATIV (telavancin) for injection VIBATIVⓇ [telavancin) for injection Acquired VibativⓇ from Theravance in November 2018 Financial terms included: - $20MM upfront payment - $5MM milestone payment in 2019 VIBATIV andhi for injection - Double-digit royalty on future net sales • Transaction included the global responsibility for the product FDA-approved product with favorable margins 750 11 garring arma 750 mg/ Rx Only Single Use Vial- Discard Unused Portion Store refrigerated at 2 (35 to 46°F). Excu ambient temperatures up 25°C (77°F) are acceptal avoid excessive heat Tance NDC 62847-001-01, elavancin) for injection VIBATIV 750 mg/vial For letravenous Infusion Only Usa Wat Pa Only Unused Porson Dispence with endles in Guide 11
View entire presentation